Aprogen Medicines Inc.
007460.KSKorea Exchange·KRW·Closed
Aprogen Medicines Inc.
007460.KSKorea Exchange·KRW·Closed
$2500.00
+1.42%
$2500.00
+$35.00 (1.42%)
52W Range
2thpctl
Volume
0.14×avg
Mkt Cap
3.51BKRW
P/E
-0.1TTM
Div Yield
–ann
Not investment advice.Read full disclaimer
Aprogen Medicines Inc. (007460.KS) annual revenue, net income, and EPS from the income statement, balance sheet, and cash flow statement (2021–2025). Full statements with 20+ years of history are available below.
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | 117.97B | -69.48B | $-52533.75 |
| 2024 | 150.11B | -58.08B | $-50552.47 |
| 2023 | 150.58B | -55.62B | $-52961.02 |
| 2022 | 78.35B | -116.08B | $-389273.61 |
| 2021 | 141.25B | -12.50B | $-43655.17 |
Continue with finqOS
Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield